Calculation of effective dose from measurements of secondary neutron spectra and scattered photon dose from dynamic MLC IMRT for 6 MV, 15 MV, and 18 MV beam energies.
about
A review of dosimetry studies on external-beam radiation treatment with respect to second cancer inductionMonte Carlo modeling of a 6 and 18 MV Varian Clinac medical accelerator for in-field and out-of-field dose calculations: development and validationRisk of secondary cancers from scattered radiation during intensity-modulated radiotherapies for hepatocellular carcinoma.A comparative study on the risk of second primary cancers in out-of-field organs associated with radiotherapy of localized prostate carcinoma using Monte Carlo-based accelerator and patient models.Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancerRisk of second malignant neoplasm following proton versus intensity-modulated photon radiotherapies for hepatocellular carcinomaSecond primary cancers after radiation for prostate cancer: a review of data from planning studiesAccuracy of out-of-field dose calculations by a commercial treatment planning system.Analytical model for out-of-field dose in photon craniospinal irradiationCalculated organ doses from selected prostate treatment plans using Monte Carlo simulations and an anatomically realistic computational phantomEstimation of second cancer risk after radiotherapy for rectal cancer: comparison of 3D conformal radiotherapy and volumetric modulated arc therapy using different high dose fractionation schemes.Conversion coefficients for determination of dispersed photon dose during radiotherapy: NRUrad input code for MCNP.The effect of photon energy on intensity-modulated radiation therapy (IMRT) plans for prostate cancer.The effect of 6 and 15 MV on intensity-modulated radiation therapy prostate cancer treatment: plan evaluation, tumour control probability and normal tissue complication probability analysis, and the theoretical risk of secondary induced malignanciesNonlinearity in MCF7 Cell Survival Following Exposure to Modulated 6 MV Radiation Fields: Focus on the Dose Gradient ZoneRisk of second cancer from scattered radiation of intensity-modulated radiotherapies with lung cancerA review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors.Neutron spectra and dose equivalents calculated in tissue for high-energy radiation therapy.Secondary neutron spectra from modern Varian, Siemens, and Elekta linacs with multileaf collimators.Effects of tertiary MLC configuration on secondary neutron spectra from 18 MV x-ray beams for the Varian 21EX linear accelerator.Modeling the risk of secondary malignancies after radiotherapy.Peripheral dose measurements for 6 and 18MV photon beams on a linear accelerator with multileaf collimator.Dose-Response Curves of the FDXR and RAD51 Genes with 6 and 18 MV Beam Energies in Human Peripheral Blood Lymphocytes.Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications.Commissioning the neutron production of a Linac: development of a simple tool for second cancer risk estimation.COMPARISON OF THE PERIPHERAL DOSES FROM DIFFERENT IMRT TECHNIQUES FOR PEDIATRIC HEAD AND NECK RADIATION THERAPY.On effective dose for radiotherapy based on doses to nontarget organs and tissues.Estimate of the uncertainties in the relative risk of secondary malignant neoplasms following proton therapy and intensity-modulated photon therapyCalculated organ doses using Monte Carlo simulations in a reference male phantom undergoing HDR brachytherapy applied to localized prostate carcinoma.Energy spectra, sources, and shielding considerations for neutrons generated by a flattening filter-free Clinac.AAPM TG 158: Measurement and calculation of doses outside the treated volume from external-beam radiation therapy.A Monte Carlo model for out-of-field dose calculation from high-energy photon therapy.Reduction in stray radiation dose using a body-shielding device during external radiation therapy.Peripheral photon and neutron doses from prostate cancer external beam irradiation.The use of LiF (TLD‐100) as an out‐of‐field dosimeter.A RapidArc planning strategy for prostate with simultaneous integrated boost.A Monte Carlo model for calculating out-of-field dose from a Varian 6MV beamDosimetric Studies of Mixed Energy Intensity Modulated Radiation Therapy for Prostate Cancer Treatments
P2860
Q24567501-631B122F-3325-4A6B-89B8-697D2568C749Q24602734-615118F8-6FEE-4207-80B6-80759EC61628Q33646315-B756B62F-2AC9-4312-8ABB-3B726B116836Q33820341-647952F7-A0F7-4B24-A66A-E26F33D99E35Q33998022-D5420517-8558-4C9E-8F1E-428A6F8B2012Q34402676-3A92725B-3F12-4DBB-A416-189F591DBE69Q34802863-B1387520-F397-4133-8EDA-7EC340751D8AQ35153259-A536BA3F-857B-4DE3-A851-50CFD25409E9Q35398974-A867CA0F-4FF8-4A0D-ABE3-AFD4CB3CAB2AQ36038149-3EBF94BE-CFE1-4348-A8FF-80D1D2616A15Q36189255-A5DE77E4-21FF-4DA9-B52F-C6A1295425A5Q36330139-3DD795A2-8047-4343-B985-0C5324984EBBQ36331821-3E2A30EC-7E69-47C9-A480-C57449703FE3Q36364402-0BE85B6F-F141-4F56-937D-5C4478B9A3C2Q36371915-8DC2AE20-5C6F-48A0-9F69-307AF41012B6Q36691114-8F5A202E-4886-4BF5-8F53-4205C9219F9EQ36819561-C3D5A753-C754-48C2-9E46-051495AC0877Q37330500-C6FC0BDE-DC3A-4C70-93D6-16B85253B8C6Q37335020-CFD2FA9D-B0CF-4CFB-B9E4-252BAB71E2D0Q37335024-CF39BC38-A108-467A-B9C5-983C2A4FE8A5Q37590488-8C70F997-52E3-4587-B23F-461BAA4D9F66Q38765382-C11A95D7-A712-4889-894E-6228BB3DD220Q38964667-832FBD23-8616-40FF-B482-9653A6AECD18Q39799109-ED3EFB93-07EC-4C11-AB98-B2E61CB4525FQ40247645-CC858556-F1E5-4D07-941C-6DAAE3B68261Q40275894-B96761BF-A39B-48AC-8D75-6C914EEE1EBCQ41477966-ED39C786-A993-422F-B9FB-7DFD98A2E146Q42020565-B7CA10D9-7C81-4FE3-A553-466B69E2E996Q43805641-90B286B6-C6E1-4182-A43A-6924C0B32EE4Q47629403-6BD1BCCB-1E6A-401C-A306-DBE32D7667C5Q47947282-482F481A-7F4B-49BE-AD32-FD11F6F1B31BQ50893168-48758E9D-4DF6-4617-8571-EA0729A3C7C8Q50956969-1E1E2FF5-047B-4349-B6CF-8B611A458A03Q53225304-6D79DEB9-6EBE-4016-ACE7-C12AC563A151Q55024116-1E93CF4D-8F4F-4102-B931-753B4A714B7AQ55154027-35663ED0-536F-420B-9DC1-A3FA4BEABF17Q57611571-EB21E94A-0510-4C00-A977-5B164E11AE0EQ59051507-C2BF0094-FD08-4D20-98B5-7A757EA9AEC1
P2860
Calculation of effective dose from measurements of secondary neutron spectra and scattered photon dose from dynamic MLC IMRT for 6 MV, 15 MV, and 18 MV beam energies.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Calculation of effective dose ...... 5 MV, and 18 MV beam energies.
@en
Calculation of effective dose ...... 5 MV, and 18 MV beam energies.
@nl
type
label
Calculation of effective dose ...... 5 MV, and 18 MV beam energies.
@en
Calculation of effective dose ...... 5 MV, and 18 MV beam energies.
@nl
prefLabel
Calculation of effective dose ...... 5 MV, and 18 MV beam energies.
@en
Calculation of effective dose ...... 5 MV, and 18 MV beam energies.
@nl
P2093
P2860
P356
P1433
P1476
Calculation of effective dose ...... 5 MV, and 18 MV beam energies.
@en
P2093
Gary D Fullerton
Jesson Hutchinson
Nolan E Hertel
Rebecca M Howell
P2860
P304
P356
10.1118/1.2140119
P407
P577
2006-02-01T00:00:00Z